|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.6 CAD | +0.12% |
|
-0.58% | -6.72% |
| Apr. 22 | BioSyent Inc.(TSXV:RX) dropped from S&P/TSX Venture Composite Index | CI |
| Apr. 01 | BioSyent To Present At LD Micro New York Investor Conference | MT |
BioSyent Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CAD 7.04 million compared to CAD 7.42 million a year ago. Net income was CAD 1.59 million compared to CAD 1.66 million a year ago.
Diluted earnings per share from continuing operations was CAD 0.13 compared to CAD 0.13 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.72% | 72.85M | |
| +30.69% | 695B | |
| +26.51% | 568B | |
| -4.47% | 361B | |
| +19.77% | 330B | |
| +3.73% | 283B | |
| +16.70% | 239B | |
| +8.78% | 204B | |
| -7.93% | 198B | |
| +8.28% | 168B |
BIOSYENT INC. 
